HIL CEO and Dr. Morry Blumenfeld live on TV, at OurCrowd’s Global Investor Summit

HIL’s CEO Mr. Sagi Brink-Danan, and Dr. Morry Blumenfeld, Venture Partner and Chairman of the Medical Advisory Board at OurCrowd, participated in a discussion livestreamed from OurCrowd’s annual Global Investor Summit in Jerusalem. OurCrowd’s event, which drew over 18,000 registrants from 183 countries, was centered around the idea of “Startups: Making a Global Impact”. In addition to the livestreamed discussion, HIL presented a model of its groundbreaking laser-proton accelerator and Mr. Brink-Danan gave a presentation to the crowd.

In the live segment, Mr. Brink-Danan and Dr. Blumenfeld discussed technology adoption in the Healthcare field in general and HIL’s solution specifically. “We at HIL aim to democratize Proton Therapy”, said Mr. Brink-Danan. While Dr. Blumenfeld emphasized the extensive reduction in side effects expected for cancer patients upon HIL’s entry to the market.

Watch the full segment: